Safety of Antiplatelet Therapy in Noncardioembolic Ischemic Stroke With Thrombocytopenia: The CASE II Study

There is scant evidence regarding the safety of antiplatelet therapy in acute ischemic stroke (AIS) patients with thrombocytopenia. Our study aims to address this concern by examining AIS patients with thrombocytopenia from a large database in real-world settings. We included patients with AIS with...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American Heart Association 2024-08, Vol.13 (16), p.e032327
Hauptverfasser:	Xu, Dongjuan, Zhou, Huan, Zhang, Tingxia, Gong, Weiwei, Zhong, Jieming, Yu, Han, Chen, Fujian, Zhong, Wansi, Yan, Shenqiang, Lou, Min
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over antiplatelet bleeding event Female Functional Status Humans ischemic stroke Ischemic Stroke - blood Ischemic Stroke - diagnosis Ischemic Stroke - drug therapy Ischemic Stroke - mortality Male Middle Aged Platelet Aggregation Inhibitors - adverse effects Platelet Aggregation Inhibitors - therapeutic use Platelet Count Propensity Score real‐world study Registries Risk Factors thrombocytopenia Thrombocytopenia - blood Thrombocytopenia - chemically induced Thrombocytopenia - diagnosis Thrombocytopenia - drug therapy Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	There is scant evidence regarding the safety of antiplatelet therapy in acute ischemic stroke (AIS) patients with thrombocytopenia. Our study aims to address this concern by examining AIS patients with thrombocytopenia from a large database in real-world settings. We included patients with AIS with a platelet count
ISSN:	2047-9980 2047-9980
DOI:	10.1161/JAHA.123.032327